Om

BlossomHill Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing small-molecule medicines for oncology and autoimmune disorders. The company’s work centers on precision drug design aimed at addressing unmet medical needs, with an emphasis on targeted therapies that can overcome resistance mechanisms seen in complex diseases. Its current portfolio includes clinical programs in cancer treatment, particularly around genetically defined tumors, alongside research efforts in immune-mediated conditions. BlossomHill Therapeutics operates as a drug discovery and development platform, combining chemistry, translational research, and early clinical testing to advance candidates from design through trial stages. Headquartered in San Diego, California and founded in 2020, BlossomHill Therapeutics plays a specialized role in the biopharmaceutical market by contributing differentiated therapies for areas where existing treatment options remain limited.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I BLOSSOMHILL THERAPEUTICS MED ENDAVU: Køb Blossomhill Therapeutics ($BLSM) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Blossomhill Therapeutics, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.